Back to Search
JEFFREY BRYAN, PHARM.D.
PHARM.D.
Oncology Pharmacist
NPI: 1851513626Individual
Specialties, Licenses & Credentials
Oncology PharmacistPrimary
Pharmacist — Oncology
Code: 1835X0200X
42788(TX)
Research & Publications (20)
ABCC8 and ABCC9: ABC transporters that regulate K+ channels.
PMID 16897043·Pflugers Arch·2007
6-review
Insulin secretagogues, sulfonylurea receptors and K(ATP) channels.
PMID 16101450·Curr Pharm Des·2005
6-review
Toward linking structure with function in ATP-sensitive K+ channels.
PMID 15561897·Diabetes·2004
6-review
Oscillations of membrane potential and cytosolic Ca(2+) concentration in SUR1(-/-) beta cells.
PMID 14872319·Diabetologia·2004
7-preclinical
Importance of specimen type in detecting human papillomavirus DNA from the female genital tract.
PMID 19626611·J Med Virol·2009
8-other
Effect of a variable prosthetic neck-shaft angle and the surgical technique on replication of normal humeral anatomy.
PMID 19651952·J Bone Joint Surg Am·2009
8-other
Streptococcus agalactiae CspA is a serine protease that inactivates chemokines.
PMID 19114481·J Bacteriol·2009
8-other
The impact of a quadrivalent human papillomavirus (types 6, 11, 16, 18) virus-like particle vaccine in European women aged 16 to 24.
PMID 19453788·J Eur Acad Dermatol Venereol·2009
8-other
Study comparing human papillomavirus (HPV) real-time multiplex PCR and Hybrid Capture II INNO-LiPA v2 HPV genotyping PCR assays.
PMID 19420164·J Clin Microbiol·2009
4-observational
Incomplete dissociation of glibenclamide from wild-type and mutant pancreatic K ATP channels limits their recovery from inhibition.
PMID 19154434·Br J Pharmacol·2009
7-preclinical
Genetic variation in the vitamin C transporter, SLC23A2, modifies the risk of HPV16-associated head and neck cancer.
PMID 19346260·Carcinogenesis·2009
8-other
The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in generally HPV-naive women aged 16-26 years.
PMID 19236279·J Infect Dis·2009
3-trial
The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in sexually active women aged 16-26 years.
PMID 19236277·J Infect Dis·2009
3-trial
Presumptive increase in protein-bound serum calcium in a dog with multiple myeloma.
PMID 19171018·Vet Clin Pathol·2009
5-case
Comparison of systemic toxicities of 177Lu-DOTMP and 153Sm-EDTMP administered intravenously at equivalent skeletal doses to normal dogs.
PMID 19223431·J Nucl Med Technol·2009
4-observational
Comparison of the quality of life of early and advanced stage ovarian cancer survivors.
PMID 19481244·Gynecol Oncol·2009
4-observational
Analysis of two KCNJ11 neonatal diabetes mutations, V59G and V59A, and the analogous KCNJ8 I60G substitution: differences between the channel subtypes formed with SUR1.
PMID 19139106·J Biol Chem·2009
8-other
Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24-45 years: a randomised, double-blind trial.
PMID 19493565·Lancet·2009
3-trial
The CiaR response regulator in group B Streptococcus promotes intracellular survival and resistance to innate immune defenses.
PMID 19114476·J Bacteriol·2009
7-preclinical
Longer term efficacy of a prophylactic monovalent human papillomavirus type 16 vaccine.
PMID 19647066·Vaccine·2009
2-rct
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1515 HOLCOMBE BLVD, BOX 0377
HOUSTON, TX 77030 - Phone
- (713) 563-6654
Quick Facts
- NPI
- 1851513626
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile